Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
Apply
Guselkumab
Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step